UroGen Pharma reports results for quarter ended September 30
The available report identifies quarterly results but provides no figures.
Related stories
Lamda Development Swings to €60.2 Million Net Loss in 9M 2026
Lamda Development reported a €60.2 million net loss for the first nine months of 2026.
M impact | EARNINGS | Nov 04, 2026, 03:34 PM UTC
National Bank of Greece Posts Slightly Higher Nine-Month Profit
M impact | EARNINGS | Nov 04, 2026, 03:32 PM UTC
Skue Sparebank reports Q3 net interest income of NOK 165.3 million
M impact | EARNINGS | Nov 04, 2026, 03:32 PM UTC
AMD Raises 2027 Expectations After Q3 Beat
Advanced Micro Devices raised its 2027 expectations after reporting a third-quarter beat, citing EPYC strength and the Helios ramp.
M impact | EARNINGS | Nov 04, 2026, 03:30 PM UTC
Suncor CEO Sees Capital Spending Tracking Toward Low End of Guidance
The CEO said weather conditions are partly behind the company tracking toward the low end of its capital spending guidance.
M impact | EARNINGS | Nov 04, 2026, 03:29 PM UTC
Wanbury reports September-quarter PAT of 118.8 million rupees
L impact | EARNINGS | Nov 04, 2026, 03:28 PM UTC